Merck’s Keytruda trial delivers boost to kidney cancer patients via @FT
https://t.co/FcXj5GnJZy— The Propell Group (@ThePropellGroup) February 12, 2019
Merck’s Keytruda trial delivers boost to kidney cancer patients via @FT
https://t.co/FcXj5GnJZy— The Propell Group (@ThePropellGroup) February 12, 2019